| 1 |
31798703 | A meta-analysis of the safety and efficacy of bosentan therapy combined with prostacyclin analogues or phosphodiesterase type-5 inhibitors for pulmonary arterial hypertension. | 2019 Dec |
1 |
| 2 |
24103713 | Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement. | 2014 Jun |
1 |
| 3 |
24826287 | Heart Transplantation in a 14-Year-Old Boy in the Presence of Severe Out-of-Proportion Pulmonary Hypertension due to Restrictive Left Heart Disease: A Case Report. | 2013 |
1 |
| 4 |
20697180 | Marked hemodynamic improvements by high-dose epoprostenol therapy in patients with idiopathic pulmonary arterial hypertension. | 2010 Oct |
3 |
| 5 |
19010174 | Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation. | 2008 Nov |
2 |
| 6 |
17403477 | Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. | 2007 Apr |
1 |
| 7 |
11878269 | Epoprostenol-induced pulmonary vasodilatation in patients with pulmonary hypertension measured by electrical impedance tomography. | 2002 Feb |
1 |